Tasuku HONJO
18Patents
11Active
18Granted
43Portfolio score
Filing activity: Sep 30, 1986 → Jan 19, 2016 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8728474B2 | Immunopotentiative composition | Emerging Cross-Sectional Technologies | 213 | Active |
| US8168179B2 | Treatment method using anti-PD-L1 antibody | Emerging Cross-Sectional Technologies | 184 | Active |
| US7563869B2 | Substance specific to human PD-1 | Chemistry; Metallurgy | 161 | Expired |
| US9073994B2 | Immunopotentiative composition | Emerging Cross-Sectional Technologies | 139 | Active |
| US9067999B1 | Immunopotentiative composition | Emerging Cross-Sectional Technologies | 136 | Active |
| US5698520A | Peptide related to human programmed cell death and DNA encoding the same | Chemistry; Metallurgy | 117 | Expired |
| US9402899B2 | Immunopotentiative composition | Emerging Cross-Sectional Technologies | 62 | Active |
| US9439962B2 | Immunopotentiative composition | Emerging Cross-Sectional Technologies | 52 | Active |
| US7998479B2 | Substance specific to human PD-1 | Chemistry; Metallurgy | 51 | Active |
| US7858746B2 | Substance that specifically recognizes PD-1 | Chemistry; Metallurgy | 50 | Active |
| US7414171B2 | PD-1-lacking mouse and use thereof | Human Necessities | 40 | Expired |
| US8951518B2 | Substance specific to human PD-1 | Chemistry; Metallurgy | 12 | Active |
| US9783609B2 | Substance specific to human PD-1 | Chemistry; Metallurgy | 6 | Active |
| US7407767B2 | Method of screening remedy for heart disease and medicinal composition for treating heart disease | Physics | 4 | Expired |
| US5416201A | DNAs that code for mouse interleuken 4 | Chemistry; Metallurgy | 1 | Expired |
| US7749758B2 | Human and mammalian stem cell-derived neuron survival factors | Physics | 0 | Active |
| US7662620B2 | Human and mammalian stem cell-derived neuron survival factors | Physics | 0 | Expired |
| US7273725B2 | Human and mammalian stem cell-derived neuron survival factors | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.